CATTLE RAISERS COMMUNITY
ANADA 200-591, Approved by FDA INDUSTRY ALLIED
For intramuscular and subcutaneous use in beef and non-lactating dairy cattle only.
BRIEF SUMMARY (For full Prescribing Information, see package insert.)
INDICATIONS: Norfenicol is indicated for treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni, and for the treatment of foot rot. Also, it is indicated for control of respiratory disease in cattle at high risk of developing BRD associated with M.haemolytica, P. multocida, and H. somni.
CONTRAINDICATIONS: Do not use in animals that have shown hypersensitivity to florfenicol.
NOT FOR HUMAN USE.
KEEP OUT OF REACH OF CHILDREN. Can be irritating to skin and eyes. Avoid direct contact with skin, eyes, and clothing. In case of accidental eye exposure, flush with water for 15 minutes. In case of accidental skin exposure, wash with soap and water. Remove contaminated clothing. Consult physician if irritation persists. Accidental injection of this product may cause local irritation. Consult physician immediately. The risk information provided here is not comprehensive. To learn more, talk about Norfenicol with your veterinarian.
For customer service, adverse effects reporting, or to obtain a copy of the MSDS or FDA-approved package insert, call 1-866-591-5777.
PRECAUTIONS: Not for use in animals intended for breeding. Effects on bovine reproductive performance, pregnancy, and lactation have not been determined. Intramuscular injection may result in local tissue reaction which persists beyond 28 days. This may result in trim loss at slaughter. Tissue reaction at injection sites other than the neck is likely to be more severe.
RESIDUE WARNINGS: Animals intended for human consumption must not be slaughtered within
28 days of the last intramuscular treatment. Animals intended for human consumption must not be slaughtered within 33 days of subcutaneous treatment. Not approved for use in female dairy cattle 20 months of age or older, including dry dairy cows as such use may cause drug residues in milk and/or in calves born to these cows. A withdrawal period has not been established in pre-ruminating calves.
Do not use in calves to be processed for veal.
ADVERSE REACTIONS: Inappetence, decreased water consumption, or diarrhea may occur transiently.
Manufactured by:
Norbrook Laboratories Limited, Newry, BT35 6PU, Co. Down, Northern Ireland.
The Norbrook logos and Norfenicol ®
are registered trademarks of Norbrook Laboratories Limited.
Updated Report Reveals Stark Realities of Feeding 9.7 Billion People by 2050
E
LANCO ANIMAL HEALTH, A SUBSIDIARY OF ELI LILLY & Co. (LLY), released an updated report in
support of its groundbreaking food security move- ment, “ENOUGH: Building a Food-Secure Tomor- row.” The report is at
ENOUGHMovement.com. The ENOUGH Movement, a global community dedicated to fi nding prac-
tical solutions for a food-secure world, is commemorating its second year by growing into a new, interactive digital report on ENOUGHmovement. com. The site fosters discussion on the global implications and realities of food security and ways to take action. “Humanity is using the resource equivalent of 1.6 earths a year, and that’s
just not sustainable for the next generation,” says Jeff Simmons, president of Elanco Animal Health. “Never has there been more urgency around dis- cussing food security; as the Earth’s population is estimated to reach 9.7 billion in 2050, experts say that will mean a 60 percent increase in demand for meat, milk and eggs. Adding more animals isn’t the answer. We need innovative solutions and collaboration to move the discussion forward.” The ENOUGH report comprises: Innovation: Evolutions in technology, animal management practices,
and innovation enable more effi cient and resource-conscious production of nutritious food. Choice: Consumers deserve the ability to choose the food that fi ts their
budget, taste, and nutritional needs, while farmers ought to be able to choose the production methods that work best for them and their farm animals. Access: Food should move from places of plenty to places of need, easing
access to affordable, nutritious food for those who need it most. Nutrition: A person’s diet should meet more than simple caloric needs
— it should provide the protein and nutrients that support healthy growth and development in children and health in adults. “Without new approaches, we won’t be able to meet the demand for safe,
suffi cient, affordable protein produced in a sustainable way,” added Sim- mons. “We must continue to fi nd new solutions and better ways to produce animal protein that protect the welfare of the animal and meet consumers’ expectations. Ultimately, we must ensure that our efforts are right for the health and welfare of animals, right for people and right by the planet.” For an opportunity to join the conversation directly, sign up at ENOUGH-
Movement.com. Discover ways to become part of the solution, take action and hear stories of those affected by food insecurity as well as those fi ght- ing to fi nd a solution. Follow the conversation on Twitter @ENOUGH2050, @Elanco, @JeffSimmons2050, and on Facebook at ENOUGH Movement and Elanco.
40 The Cattleman December 2015
thecattlemanmagazine.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124